<html><body><h2>Case: 2577155</h2><h3> CDS Time: 1969-11-30</h3>
<patient name=2577155>
69.0 year old Other_Race Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">69</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">142</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">121</td><td width="200">1969-8-19</td></tr>
<tr><td width="200">Chloride</td><td width="200">94.0</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">51</td><td width="200">1969-8-19</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">69</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">BNP</td><td width="200">10421.0</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Weight</td><td width="200">139</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">HbA1C</td><td width="200">7</td><td width="200">1969-10-29</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">80</td><td width="200">1969-8-19</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">188</td><td width="200">1969-8-19</td></tr>
<tr><td width="200">SGOT</td><td width="200">35</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">163</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Height</td><td width="200">62</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">188</td><td width="200">1969-8-19</td></tr>
<tr><td width="200">BUN</td><td width="200">29</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">HCT</td><td width="200">32</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">HGB</td><td width="200">11</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">Sodium</td><td width="200">130</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.7</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">7</td><td width="200">1969-10-29</td></tr>
<tr><td width="200">Pulse</td><td width="200">71</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">PLT</td><td width="200">424</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">WBC</td><td width="200">8</td><td width="200">1969-11-18</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1969-11-6</td></tr>
<tr><td width="200">SGPT</td><td width="200">47</td><td width="200">1969-11-16</td></tr>
<tr><td width="200">CVA</td><td width="200"></td><td width="200">1969-6-14</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">Other_Race</td><td width="200"></td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1969-11-16</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1969-8-18</td></tr>
<tr><td width="200">diarrhea</td><td width="200"></td><td width="200">1969-11-30</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1969-6-18</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1969-11-17</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1969-9-8</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1969-11-6</td></tr>
</table>
<p><b>Medications:</b> aspirin(324.0) labetalol(5.0) simvastatin(40.0) lisinopril(40.0) hydralazine(60.0) furosemide(60.0) Insulin(24.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(163/null) && Treatment_Diastolic_BP(69/null)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(130.0/1969-11-18)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Significant hyponatremia[Sodium(130.0/1969-11-18)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(5.0/1969-11-18)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null)]()</td></tr>
<tr><td width="200">MI_with_high_BP</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[presence of MI && Treatment_Systolic_BP(163/null)]()</td></tr>
<tr><td width="200">Diabetes WITHOUT proteinuria/renal manifestations</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of diabetes mellitus && Absence of diabetic with renal manifestations && Absence of diabetic nephropathy && Absence of diabetic nephrosis && Proteinuria equals trace or above && Absence of ARB]()</td></tr>
<tr><td width="200">MI (BP not controlled)</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Sodium=<125 ever</td>
<td width="200"></td>
<td width="200"> hyponatremia in the past[Sodium(130.0/1969-11-18)]()</td></tr>
<tr><td width="200">DM and BP not controlled</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of DM && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null)]()</td></tr>
<tr><td width="200">DM BP not controlled  >=1 drug</td>
<td width="200"></td>
<td width="200"> Diabetes[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of diabetes mellitus && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(69.0/1970-1-1)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(69.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(5.0/1969-11-18) && presence of MI]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1969-08-18</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-06-14</td>
<td width="200"> CVA()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1969-06-18</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-11-17</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-11-16</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1969-09-08</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(5.0/1969-11-18) && presence of MI]()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1969-11-06</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(5.0/1969-11-18) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1969-11-30</td>
<td width="200"> diarrhea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">VA/JNC-VII Hypertension Guideline</h1>
<b>Patient classification:</b> <ul>
<li>VA/JNC-VII Hypertension Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(presence of diagnosis of hypertension && absence of renovascular disease && no diagnosis of pregnancy && Absense of Secondary Hypertension && absence of spinal cord injury && absence of narcolepsy && Not taking cyclosporine && Not taking spironolactone && Not taking minoxidil && absence of renovascular disease && absence of IHSS && Absence of Ascites && Not off guideline && not taking tacrolimus && absence of transplant recipient && Absence of a dialysis procedure code)</i>]
<li>Risk Group C (presence of TOD/CCD or DM): [because <i> presence of TOD/CCD or DM </i> evaluate to <b>true</b><i>(presence of DM)</i>]
</ul>
<b>Scenario choice:</b> on two or three anti-hypertensive drugs
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(163/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Recommendation</b>
<ul>
<li>Beta blockers may have transient adverse effects on lipids in some patients.  Consider repeating lipid profile after maximal dosage of drug has been reached if appropriate.
<li>It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: furosemide, hydralazine, Insulin, labetalol, lisinopril
<li>The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>Primary_Recommendation</b>
<ul>
<li>Recommend INTENSIFYING antihypertensive therapy: BP MARKEDLY ELEVATED based on most recent available BP; F/up 1month.
<li>Based on most recent BP in the database, BP appears to be adequately controlled; however, ALTERNATIVE DRUGS may be preferred
</ul>
<li><b>Assumption</b>
<ul>
<li>We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>on medication: things to check</b><br>
<ul>
<li><b>assumption  check presence of BP <font color=FF0000>preferred</font></b>(rule in criterion<i> diastolic BP or systolic BP absent</i> evaluate to <b> true</b> because <i>absence of diastolic BP</i>)])
We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
<li><b>adverse event warning <font color=FF0000>preferred</font></b>(rule in criterion<i> presence of current medication with adverse reaction</i> evaluate to <b> true</b> because <i>presence of current medication with adverse reaction</i>)])
<li><b>Beta blocker and diabetes <font color=FF0000>preferred</font></b>(rule in criterion<i> On beta blocker and DM</i> evaluate to <b> true</b> because <i>presence of DM && beta blocker being used</i>)])
Beta blockers may mask symptoms of hypoglycemia and should be used with caution.
<li><b>On beta blocker hyperlipidemia <font color=FF0000>preferred</font></b>(rule in criterion<i> beta blocker being used</i> evaluate to <b> true</b> because <i>beta blocker being used</i>)])
Beta blockers may have transient adverse effects on lipids in some patients.  Consider repeating lipid profile after maximal dosage of drug has been reached if appropriate.
<li><b>test parameterized message <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: furosemide, hydralazine, Insulin, labetalol, lisinopril
<li><b>Disclaimer <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>two or three drug-therapy choices</b><br>
<ul>
<li><b>Blood pressure not adequately controlled. Intensify drug treatment <font color=FF0000>preferred</font></b>(strict rule-in condition<i> BP not adequately controlled based on most recent BP</i> evaluate to <b> true</b> because <i>BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null)</i>)])
Recommend INTENSIFYING antihypertensive therapy: BP MARKEDLY ELEVATED based on most recent available BP; F/up 1month.
<li><b>substitute labetalol w BB <font color=FF0000>preferred</font></b>(strict rule-in condition<i> presence of labetatalol, MI, absence of BPH</i> evaluate to <b> true</b> because <i>absence of BPH && presence of MI && Taking labetalol</i>)])

Based on most recent BP in the database, BP appears to be adequately controlled; however, ALTERNATIVE DRUGS may be preferred
</ul>
<li><b>step up choices</b><br>
<ul>
<li><b>evaluate increasing dose (no MI, verapamil/diltz) <font color=FF0000>preferred</font></b>(strict rule-in condition<i> there exists non-contraindicated drug not at maximum dose</i> evaluate to <b> true</b> because <i>there exists non-contraindicated drug not at maximum dose</i>)])

<li><b>evaluate new drug to prescribe <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

</ul>
<li><b>substitution messages</b><br>
<ul>
</ul>
<li><b>increase dose considerations</b><br>
<ul>
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>Cardioselective Beta Blocker (metoprolol)<ul><li>Drugs with bad interactions:  Alpha_beta_blockers(labetalol) <li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction)  Heart_Failure(Cardiomegaly, Heart_Failure) </font><li>Relative indications:  Diabetes_Mellitus(DM-Type2) <li>preference: ruled out</ul><li>DHP Calcium Channel Blocker (felodipine, nifedipine SA)<ul><li>Drugs to partner:  Beta-Blockers(labetalol) <li>Relative indications:  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of myocardial infarction])  Diabetes_Mellitus(DM-Type2) <li>preference: preferred</ul><li>Angiotensin II Receptor Blocker (irbesartan)<ul><li>Drugs with bad interactions:  ACE_Inhibitors(lisinopril) <li>Relative indications:  Diabetes_Mellitus(DM-Type2)  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Potassium Sparing Diuretic <ul><li>preference: neutral<li>No comment</ul><li>Alpha Blocker (terazosin)<ul><li>preference: neutral<li>No comment</ul><li>(non-DHP) Calcium Channel Blocker (diltiazem)<ul><li>Drugs with bad interactions:  Beta-Blockers(labetalol) <li>Relative indications:  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of myocardial infarction]) <li>Relative contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>ACE Inhibitor (lisinopril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Heart_Failure(Cardiomegaly, Heart_Failure)  Cerebral_Vascular_Diseases(Occulusion of cerebral arteries, CVA)  Diabetes_Mellitus(DM-Type2)  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of myocardial infarction]) </font><li>preference: ruled out</ul><li>Thiazide Diuretic (HCTZ)<ul><li>Drugs with bad interactions:  furosemide(furosemide) <li><font color=FF0000>Compelling indications:  Cerebral_Vascular_Diseases(Occulusion of cerebral arteries, CVA)  taking >= 2 anti hypertensive meds(Combination therapy for HTN[Antihypertensive_Agents])  Diabetes_Mellitus(DM-Type2) </font><li>Contraindications:  Sodium_Very_Low(<=130) most recent(Significant hyponatremia[Sodium(130.0/1969-11-18)]) <li>Relative indications:  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(163/null) && presence of myocardial infarction]) <li>Relative contraindications:  Sodium-Low(hyponatremia[Sodium(130.0/1969-11-18)])  Sodium=<125 ever(hyponatremia in the past[Sodium(130.0/1969-11-18)]) <li>preference: ruled out</ul></ul></body></html>